Liquid Biopsy Market in Transplant Monitoring: Graft Rejection Detection 2025–2035
Market Synopsis:
The market for liquid biopsies is quickly becoming a revolutionary force in precision medicine and cancer detection. A non-invasive diagnostic method called liquid biopsy uses blood or other bodily fluids to find cancer-related biomarkers such circulating tumor DNA (ctDNA), exosomes, or circulating tumor cells (CTCs). It provides a substitute for conventional tissue biopsies,...
0 Comments
0 Shares